📝 Pentokey Organy India Ltd — results explained
Quarter ended March 2026 (Q4 FY26)
Pentokey Organy India Ltd reported revenue of ₹-2 crore for the quarter ended March 2026 (Q4 FY26), down 404.9% from ₹1 crore in the same quarter last year, and up 11.0% sequentially over the December 2025 quarter.
The company reported a net loss of ₹0 crore, against a net profit of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.21.
Operating profit stood at ₹-0 crore — an operating margin (OPM) of 16.7%, compared with -3.3% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Pentokey Organy India Ltd posted revenue of ₹2 crore, a growth of 151.8% over FY25, with a net profit of ₹0 crore (down 23.1% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2 crore with a net profit of ₹0 crore.
Valuation snapshot
At the current price of ₹35.99, 524210 has a market capitalisation of ₹23 crore and a trailing P/E of about 112.8.
Within the Commodity Chemicals industry, it is the 25th-largest of the 50 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 73.03%, domestic institutional investors (DIIs) 2.30%, public shareholders 24.67% of Pentokey Organy India Ltd.